Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
1,095,921
-
Shares change
-
+140,695
-
Total reported value, excl. options
-
$170,839,038
-
Value change
-
+$21,684,376
-
Put/Call ratio
-
54%
-
Number of buys
-
28
-
Number of sells
-
-44
-
Price
-
$156.05
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q2 2023
123 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q2 2023.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,095,921 shares
.
Largest 10 shareholders include Miller Investment Management, LP (176,376 shares), GOLDMAN SACHS GROUP INC (115,990 shares), MORGAN STANLEY (68,913 shares), JPMORGAN CHASE & CO (66,900 shares), Qube Research & Technologies Ltd (62,168 shares), BANK OF AMERICA CORP /DE/ (48,042 shares), LPL Financial LLC (45,985 shares), MOGY JOEL R INVESTMENT COUNSEL INC (36,880 shares), Royal Bank of Canada (32,109 shares), and Consolidated Investment Group LLC (29,700 shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.